出生前検査と新生児スクリーニング市場レポート：2030年までの動向、予測、競合分析

出生前検査と新生児スクリーニングの動向と予測

世界の出生前検査＆新生児スクリーニング市場は、2024年から2030年までのCAGRが12.8％で、2030年までに推定108億米ドルに達すると予想されます。この市場の主な促進要因は、遺伝性疾患の有病率の増加と赤ちゃんの染色体症候群の症例の増加です。出生前検査と新生児スクリーニングの世界市場の将来は、病院と診断センター市場における機会で有望に見えます。

出生前検査と新生児スクリーニング市場の洞察

Lucintelの予測では、非侵襲的検査は胎児へのリスクがなく、流産の可能性も低いため、予測期間中に高い成長が見込まれます。

病院は、十分な情報に基づいた意思決定を行うためにこの施設を好む患者が増加しているため、予測期間中に高い成長が見込まれます。

北米は、遺伝性疾患の症例数が増加していることと、同地域に有利な償還政策が存在することから、予測期間中に最も高い成長が見込まれます。

本レポートでは、以下の11の主要な質問に回答している：

• Q.1.市場セグメントのうち、最も有望かつ高成長な機会は何か？
• Q.2.どのセグメントがより速いペースで成長するのか、またその理由は？
• Q.3.今後成長が加速すると思われる地域とその理由は？
• Q.4.市場力学に影響を与える主な要因は何か？市場における主な課題とビジネスリスクは？
• Q.5.この市場におけるビジネスリスクと競合の脅威は？
• Q.6.この市場における新たな動向とその理由は？
• Q.7.市場における顧客の需要の変化にはどのようなものがありますか？
• Q.8.この市場における新たな開発と、その開発をリードしている企業は？
• Q.9.この市場における主要企業は？主要企業は事業成長のためにどのような戦略的取り組みを進めているのか？
• Q.10.この市場における競合製品にはどのようなものがあり、材料や製品の代替による市場シェア低下の脅威はどの程度ありますか？
• Q.11.過去5年間にどのようなM&Aが行われ、業界にどのような影響を与えましたか？

目次

第1章 エグゼクティブサマリー

第2章 世界の出生前検査および新生児スクリーニング市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

• マクロ経済動向（2018～2023年）と予測（2024～2030年）
• 世界の出生前検査および新生児スクリーニング市場の動向（2018～2023年）と予測（2024～2030年）
• 診断タイプ別の世界の出生前検査および新生児スクリーニング市場
  • 侵襲的
  • 非侵襲的
• テクノロジー別の世界の出生前検査および新生児スクリーニング市場
  • スクリーニング技術
  • 診断技術
• 最終用途別の世界の出生前検査および新生児スクリーニング市場
  • 病院
  • 診断センター
  • その他

第4章 2018年から2030年までの地域別の市場動向と予測分析

• 地域別の世界の出生前検査および新生児スクリーニング市場
• 北米の出生前検査および新生児スクリーニング市場
• 欧州の出生前検査および新生児スクリーニング市場
• アジア太平洋の出生前検査および新生児スクリーニング市場
• その他地域出生前検査および新生児スクリーニング市場

第5章 競合の分析

• 製品ポートフォリオ分析
• 運用上の統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

• 成長機会分析
  • 診断タイプ別の世界の出生前検査および新生児スクリーニング市場の成長機会
  • テクノロジー別の世界の出生前検査および新生児スクリーニング市場の成長機会
  • 最終用途別の世界の出生前検査および新生児スクリーニング市場の成長機会
  • 地域別の世界の出生前検査および新生児スクリーニング市場の成長機会
• 世界の出生前検査および新生児スクリーニング市場の新たな動向
• 戦略的分析
  • 新製品の開発
  • 世界の出生前検査および新生児スクリーニング市場の能力拡大
  • 世界の出生前検査および新生児スクリーニング市場における合併、買収、合弁事業
  • 認証とライセンシング

第7章 有力企業の企業プロファイル

• PerkinElmer
• Natera
• Invitae
• Centogene
• Cradle Genomics
• Hoffmann-La Roche
• Quest Diagnostics
• Baebies
• Ravgen
• Eurofins Scientific

Prenatal Testing & Newborn Screening Trends and Forecast

The future of the global prenatal testing & newborn screening market looks promising with opportunities in the hospital and diagnostic center markets. The global prenatal testing & newborn screening market is expected to reach an estimated $10.8 billion by 2030 with a CAGR of 12.8% from 2024 to 2030. The major drivers for this market are growing prevalence of genetic disorders and rising cases of chromosome syndrome in babies.

A more than 150-page report is developed to help in your business decisions.

Prenatal Testing & Newborn Screening by Segment

The study includes a forecast for the global prenatal testing & newborn screening by diagnostic type, technology, end use, and region.

Prenatal Testing & Newborn Screening Market by Diagnostic Type [Shipment Analysis by Value from 2018 to 2030]:

• Invasive
• Non-Invasive

Prenatal Testing & Newborn Screening Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

• Screening Technology
• Diagnostic Technology

Prenatal Testing & Newborn Screening Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals
• Diagnostic Centers
• Others

Prenatal Testing & Newborn Screening Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Prenatal Testing & Newborn Screening Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies prenatal testing & newborn screening companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the prenatal testing & newborn screening companies profiled in this report include-

• Perkinelmer
• Natera
• Invitae
• Centogene
• Cradle Genomics
• Hoffmann-La Roche
• Quest Diagnostics
• Baebies
• Ravgen
• Eurofins Scientific

Prenatal Testing & Newborn Screening Market Insights

Lucintel forecasts that non-invasive is expected to witness higher growth over the forecast period due to its capacity to impose no risk to the fetus and lower the chance of miscarriage.

Hospital is expected to witness higher growth over the forecast perioddue to growing patients preference for this facility to make informed decisions.

North America is expected to witness highest growth over the forecast period due to growing number of genetic disorders cases and presence of favourable reimbursement policy in the region.

Features of the Global Prenatal Testing & Newborn Screening Market

Market Size Estimates: Prenatal testing & newborn screening market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Prenatal testing & newborn screening market size by diagnostic type, technology, end use, and region. in terms of value ($B).

Regional Analysis: Prenatal testing & newborn screening market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different diagnostic types, technologies, end uses, and region.s for the prenatal testing & newborn screening market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the prenatal testing & newborn screening market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1. What is the prenatal testing & newborn screening market size?

Answer: The global prenatal testing & newborn screening market is expected to reach an estimated $10.8 billion by 2030.

Q.2. What is the growth forecast for prenatal testing & newborn screening market?

Answer: The global prenatal testing & newborn screening market is expected to grow with a CAGR of 12.8% from 2024 to 2030.

Q.3. What are the major drivers influencing the growth of the prenatal testing & newborn screening market?

Answer: The major drivers for this market are growing prevalence of genetic disorders and rising cases of chromosome syndrome in babies.

Q.4. What are the major segments for prenatal testing & newborn screening market?

Answer: The future of the prenatal testing & newborn screening market looks promising with opportunities in the hospital and diagnostic center markets.

Q.5. Who are the key prenatal testing & newborn screening market companies?

Answer: Some of the key prenatal testing & newborn screening companies are as follows:

• PerkinElmer
• Natera
• Invitae
• Centogene
• Cradle Genomics
• Hoffmann-La Roche
• Quest Diagnostics
• Baebies
• Ravgen
• Eurofins Scientific

Q.6. Which prenatal testing & newborn screening market segment will be the largest in future?

Answer: Lucintel forecasts that non-invasive is expected to witness higher growth over the forecast period due to its capacity to impose no risk to the fetus and lower the chance of miscarriage.

Q.7. In prenatal testing & newborn screening market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to growing number of genetic disorders cases and presence of favourable reimbursement policy in the region.

Q.8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the prenatal testing & newborn screening market by diagnostic type (invasive and non-invasive), technology (screening technology and diagnostic technology), end use (hospitals, diagnostic centers, and others), and region. (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Prenatal Testing & Newborn Screening Market: Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Prenatal Testing & Newborn Screening Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Prenatal Testing & Newborn Screening Market by Diagnostic Type
  • 3.3.1: Invasive
  • 3.3.2: Non-Invasive
• 3.4: Global Prenatal Testing & Newborn Screening Market by Technology
  • 3.4.1: Screening Technology
  • 3.4.2: Diagnostic Technology
• 3.5: Global Prenatal Testing & Newborn Screening Market by End Use
  • 3.5.1: Hospitals
  • 3.5.2: Diagnostic Centers
  • 3.5.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Prenatal Testing & Newborn Screening Market by Region
• 4.2: North American Prenatal Testing & Newborn Screening Market
  • 4.2.2: North American Prenatal Testing & Newborn Screening Market by End Use: Hospitals, Diagnostic Centers, and Others
• 4.3: European Prenatal Testing & Newborn Screening Market
  • 4.3.1: European Prenatal Testing & Newborn Screening Market by Diagnostic Type: Invasive and Non-Invasive
  • 4.3.2: European Prenatal Testing & Newborn Screening Market by End Use: Hospitals, Diagnostic Centers, and Others
• 4.4: APAC Prenatal Testing & Newborn Screening Market
  • 4.4.1: APAC Prenatal Testing & Newborn Screening Market by Diagnostic Type: Invasive and Non-Invasive
  • 4.4.2: APAC Prenatal Testing & Newborn Screening Market by End Use: Hospitals, Diagnostic Centers, and Others
• 4.5: ROW Prenatal Testing & Newborn Screening Market
  • 4.5.1: ROW Prenatal Testing & Newborn Screening Market by Diagnostic Type: Invasive and Non-Invasive
  • 4.5.2: ROW Prenatal Testing & Newborn Screening Market by End Use: Hospitals, Diagnostic Centers, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Prenatal Testing & Newborn Screening Market by Diagnostic Type
  • 6.1.2: Growth Opportunities for the Global Prenatal Testing & Newborn Screening Market by Technology
  • 6.1.3: Growth Opportunities for the Global Prenatal Testing & Newborn Screening Market by End Use
  • 6.1.4: Growth Opportunities for the Global Prenatal Testing & Newborn Screening Market by Region
• 6.2: Emerging Trends in the Global Prenatal Testing & Newborn Screening Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Prenatal Testing & Newborn Screening Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Prenatal Testing & Newborn Screening Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: PerkinElmer
• 7.2: Natera
• 7.3: Invitae
• 7.4: Centogene
• 7.5: Cradle Genomics
• 7.6: Hoffmann-La Roche
• 7.7: Quest Diagnostics
• 7.8: Baebies
• 7.9: Ravgen
• 7.10: Eurofins Scientific